Taxol precursors produced in engineered E coli
Cost-effective, large-scale production of oncology drug Taxol (paclitaxel) intermediates could eventually be achieved using engineered Escherichia coli.
iBio, GE partner to work on plant-based production tech
iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology.
Celleuxs launches “broad cell line” disposable bioreactor
Cellexus has expanded its disposable bioreactor offering with a unit designed to give biomanufacturers greater flexibility in their choice of cell lines.
Pall and New Brunswick partner on disposable bioreactors
Pall and New Brunswick have teamed up to develop and supply new disposable bioreactor technologies, targeting growing demand for products that improve quality and reduce cost of biomanufacturing.
Charles River Laboratories (CRL) is to acquire WuXi PharmaTech for $1.6bn (€1.2bn), creating a global CRO capable of offering fully integrated services from molecule creation to first-in-human testing.
ATMI introduces disposable bioreactor
ATMI is using Interphex 2010 to launch the Integrity PadReactor, a disposable bioreactor designed to provide a highly scalable entry point in its line of mixing and process manufacturing systems.
Eden Biodesign and Millipore partner on cell line tech
Access to Millipore’s UCOE expression technology though a new partnership is “step change” for customers, says contract manufacturing organization (CMO) Eden Biodesign.
Sartorius launches single-use biomanufacturing range
Sartorius Stedim Biotech has introduced FlexAct BP, the first product in a range which will be an integrated single-use system for entire biomanufacturing steps in upstream and downstream processing.
Millipore rolls out CellReady 3L benchtop bioreactor
Millipore has expanded its Mobius process technology range with the new CellReady 3L bench-top bioreactor.
Avid’s revenues rise 74%; discusses expansion plans
CMO Avid Bioservices’ revenues rose by 74 per cent to $2.1m (€1.5m) in Q2, generating a further $7m from its parent company, and it has plans to boost output and become a leader in mammalian cell culture production.
Rollprint service aims to cut time to market
Rollprint Packaging Products claims that its prototype laboratory can help cut time to market by providing information about how packaging will behave in the commercial environment.
Novasep buys to get big in bio
Novasep has bolstered its upstream processing capabilities by acquiring Henogen, a Belgium-based CMO that has biotech development and cGMP manufacturing expertise.
US CMOs economy proof in the long term, says F&S
The US contract manufacturing sector is strong enough to bounce back from any short-term slow down caused by the credit crisis, according to a new report by Frost & Sullivan (F&S).
Alliance launches animal-free culture supplement
Novozymes and Millipore have launched an animal-free culture supplement, which has been designed to reduce risk and regulatory pressures in upstream biopharmaceutical processes.
Pall hopes to have manufacturing in the bag
Pall Life Sciences has launched its Allegro 3D biocontainers, which have been designed to improve the performance of the company’s large-scale, single use manufacturing systems.